Negotiate or collaborate?
In an ever-changing pharmaceutical landscape, successfully bringing a concept to market — and to patients — involves many different stakeholders. How do industry leaders navigate this journey most effectively?
FACILITATED BY
KATHRYN SIMPSON | Business Consultant| Kathryn Simpson Consulting
PANELLISTS INCLUDE
MALCOLM BARRATT-JOHNSON | Managing Director | PharmaMedic Consultancy Ltd
TERRI GASKELL | Chief Technical Officer | Rinri Therapeutics Ltd.
EMILY MERRELL | Interim Head of ATTC Network Coordination | Cell and Gene Therapy Catapult
NADINE CLEMO | Drug Discovery Program Director | Apollo Therapeutics